Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Moodys
UBS
Fuji
Harvard Business School
Teva
Deloitte
QuintilesIMS
Daiichi Sankyo

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,787,529

« Back to Dashboard

Which drugs does patent 6,787,529 protect, and when does it expire?

Patent 6,787,529 protects TACLONEX and is included in one NDA.

This patent has twenty-nine patent family members in twenty-two countries.
Summary for Patent: 6,787,529
Title: Topical composition
Abstract:The present invention relates to a pharmaceutical gel composition for application on skin, said composition comprising at least one vitamin D or vitamin D analogue and at least one corticosteroid as well as a viscosity-increasing excipient.
Inventor(s): H.o slashed.y; Gert (Jyllinge, DK), Didriksen; Erik Johannes (Ballerup, DK)
Assignee: Leo Pharmaceutical Products Ltd. A/S (Ballerup, DK)
Application Number:09/984,072
Patent Claim Types:
see list of patent claims
Composition; Compound; Use;

Drugs Protected by US Patent 6,787,529

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene hydrate SUSPENSION;TOPICAL 022185-001 May 9, 2008 RX Yes Yes ➤ Sign Up ➤ Sign Up Y PLAQUE PSORIASIS ➤ Sign Up
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene hydrate SUSPENSION;TOPICAL 022185-001 May 9, 2008 RX Yes Yes ➤ Sign Up ➤ Sign Up Y PSORIASIS ➤ Sign Up
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene hydrate SUSPENSION;TOPICAL 022185-001 May 9, 2008 RX Yes Yes ➤ Sign Up ➤ Sign Up Y TREATMENT OF MODERATE PLAQUE PSORIASIS ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Cipla
US Department of Justice
Moodys
Accenture
Boehringer Ingelheim
Teva
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.